Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

762.73 -22.30 (-2.84%)
Official Closing Price Updated: 4:10 PM EDT, Jun 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,123,914
Open 786.00
Bid (Size) 760.00 (13)
Ask (Size) 762.73 (1)
Prev. Close 785.03
Today's Range 755.56 - 786.00
52wk Range 677.09 - 972.53
Shares Outstanding N/A
Dividend Yield 0.79%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Obesity Drugs Help With Weight Loss But Are Adding Fat Elsewhere
The U.S. trade deficit with Ireland has surged as $36 billion in hormone shipments for weight-loss and diabetes drugs were flown in to meet demand and avoid tariffs. 
Via Benzinga
Uncover the latest developments among S&P500 stocks in today's session.
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
Via Chartmill

Performance

YTD
-2.0%
-2.0%
1 Month
+2.1%
+2.1%
3 Month
-9.5%
-9.5%
6 Month
+0.7%
+0.7%
1 Year
-13.9%
-13.9%

More News

Read More
3 'Underdog Stocks' For The Rest Of 2025
Via Benzinga
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
Via Benzinga
Exposures Product Safety
Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week
Via The Motley Fool
Stay informed with the top movers within the S&P500 index on Friday.
Via Chartmill
Friday's session: gap up and gap down stock in the S&P500 index
Via Chartmill
Looking At Eli Lilly's Recent Unusual Options Activity
Via Benzinga
Forecasting The Future: 7 Analyst Projections For Eli Lilly
Via Benzinga
3 Unpopular Stocks Facing Headwinds
Via StockStory
How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl
Via Investor's Business Daily
Exposures Product Safety
5 Growth Stocks to Invest $1,000 in Right Now
Via The Motley Fool
Topics Artificial Intelligence Economy World Trade
Exposures Artificial Intelligence Economy Tariff
Q1 Earnings Outperformers: Eli Lilly (NYSE:LLY) And The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Gilead Sciences Wins Approval For Highly Effective HIV Prevention Drug
Via Investor's Business Daily
Scholar Rock Stock Soars After Investigational Drug Helps Preserve Lean Mass: Retail Flags Lack Of Incremental Weight Loss
Via Stocktwits
Topics Death
Exposures Death
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
Via Benzinga
Why Scholar Rock Shares Are Soaring Today
Via The Motley Fool
Topics Stocks
Exposures US Equities
Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study
Via Benzinga
Nobody Wants To Touch Healthcare Stocks Now – That Might Be A Big Mistake
Via Benzinga
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
Via The Motley Fool
Novo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy?
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)
Via The Motley Fool
Topics Government World Trade
Exposures Political Tariff
Market Monitor News June 18 (Jabil, Reddit & Verve Therapeutics UP - Solar Stocks First Solar, Sunrun & SolarEdge DOWN)
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)
From Brodsky & Smith LLC
Via GlobeNewswire
Why Verve Therapeutics Stock Is Skyrocketing Today
Via The Motley Fool

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 762.73
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 06/20/25 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.